WDB coco Co's book value per share for the quarter that ended in Dec. 2023 was 円1,363.86.
During the past 12 months, WDB coco Co's average Book Value Per Share Growth Rate was 25.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 29.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 38.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of WDB coco Co was 42.80% per year. The lowest was 29.20% per year. And the median was 39.90% per year.
WDB coco Co's current price is 円3445.00. Its book value per share for the quarter that ended in Dec. 2023 was 円1,363.86. Hence, today's PB Ratio of WDB coco Co is 2.53.
During the past 6 years, the highest P/B Ratio of WDB coco Co was 9.62. The lowest was 2.29. And the median was 5.26.
Good Sign:
WDB coco Co Ltd stock PB Ratio (=2.35) is close to 5-year low of 2.29
WDB coco Co Book Value per Share Historical Data
The historical data trend for WDB coco Co's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WDB coco Co's Book Value per Share
For the Health Information Services subindustry, WDB coco Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WDB coco Co's PB Ratio Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, WDB coco Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where WDB coco Co's PB Ratio falls into.
WDB coco Co Book Value per Share Calculation
WDB coco Co's Book Value Per Share for the fiscal year that ended in Mar. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
WDB coco Co (TSE:7079) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
WDB coco Co Book Value per Share Related Terms
Thank you for viewing the detailed overview of WDB coco Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7079 has been successfully added to your 